Clearside Biomedical (FRA:CLM) Other Long Term Assets : €0.03 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Clearside Biomedical Other Long Term Assets?

Clearside Biomedical's other long-term assets for the quarter that ended in Sep. 2024 was €0.03 Mil.

Clearside Biomedical's quarterly other long-term assets increased from Mar. 2024 (€0.03 Mil) to Jun. 2024 (€0.03 Mil) but then stayed the same from Jun. 2024 (€0.03 Mil) to Sep. 2024 (€0.03 Mil).

Clearside Biomedical's annual other long-term assets declined from Dec. 2021 (€0.14 Mil) to Dec. 2022 (€0.03 Mil) and declined from Dec. 2022 (€0.03 Mil) to Dec. 2023 (€0.03 Mil).

Clearside Biomedical Other Long Term Assets Historical Data

The historical data trend for Clearside Biomedical's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearside Biomedical Other Long Term Assets Chart

Clearside Biomedical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

0.32

0.21

0.14

0.03

Clearside Biomedical Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long Term Assets	Get a 7-Day Free Trial															0.03	0.03	0.03	0.03	0.03

Clearside Biomedical Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Clearside Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearside Biomedical Inc (FRA:CLM) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

CLSD:USA

Address

900 North Point Parkway, Suite 200, Alpharetta, GA, USA, 30005

Website

https://www.clearsidebio.com

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.